Drug Approval | July 26, 2023
NATCO files generic Erdafitinib Tablets in USA
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
1. 10 crore teleconsultations have been rendered to senior citizens and 5,22,15,224 to women
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
Subscribe To Our Newsletter & Stay Updated
